Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(337)
•••
Comment by jayjay2020on May 07, 2019 11:45am
117 Views
Post# 29719845

RE:RE:RE:RE:RE:RE:RE:RE:Irwin does have a US play

RE:RE:RE:RE:RE:RE:RE:RE:Irwin does have a US play
INVSTIGAT0R wrote:
The whole article is just bashing Aphria and coming up with reasons why GGB would not get involved with us lol. Basically just said our brands, international operations and Canadian operations are all of marginal value.
All I am saying is I think the Schottensteins are pulling some strings at APHA. The $300M debenture coming up as soon as the GGB offer is expired just makes me think they are all connected. GGB wanted to own APHA.  This is an indirect way for GGB through Schottensteins to own  part of it in the future. I am ok with it if that is the case because they did not dilute shares and if Schottenstein's are commited to APHA I welcome them aboard.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities